Artemis Medicare Services Ltd (ARTEMISMED)
₹293.20
Mkt cap
₹4,642 Cr
P/E ratio
39.90
P/B
4.68
Div yield
0.15%
ROE
11.90%
ROCE
14.50%
EPS (TTM)
₹7.35
Book value
₹63
52W range
203–379
Sector
Healthcare
Price history
Previous close
Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1] [2]
NSE ARTEMISMEDBSE 542919
Health check
Mixed
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−22.60% from high₹293
₹203+44.18% from low₹379
Current
₹293.20
Prev close
₹297.95
Day
−1.59%
Price performance
1D
−0.60%
1W
+3.93%
1M
−19.22%
3M
−1.99%
6M
+23.46%
1Y
+21.37%
YTD
+6.17%
Financials
Revenue, profit & margin
P/E ratio
39.9×
ARTEMISMED is 10% below the sector median of 44.4×
ARTEMISMED39.9×
Sector median44.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 217 | 210 | 217 | 217 | 235 | 227 | 235 | 250 | 270 | 267 | 274 | 282 | 306 | |
| Expenses | 184 | 179 | 181 | 181 | 193 | 190 | 199 | 209 | 220 | 223 | 224 | 227 | 252 | |
| Operating Profit | 33 | 32 | 36 | 36 | 42 | 37 | 36 | 41 | 50 | 44 | 50 | 55 | 54 | |
| OPM % | 15% | 15% | 17% | 16% | 18% | 16% | 15% | 16% | 19% | 16% | 18% | 20% | 18% | |
| Other Income | 2 | 2 | 2 | 4 | 8 | 9 | 12 | 7 | 8 | 4 | 8 | 5 | 8 | |
| Interest | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 | 7 | |
| Depreciation | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 12 | 14 | |
| Profit before tax | 19 | 16 | 19 | 22 | 31 | 27 | 29 | 30 | 40 | 30 | 39 | 42 | 41 | |
| Tax % | 27% | 29% | 28% | 24% | 27% | 23% | 20% | 29% | 25% | 24% | 25% | 26% | 24% | |
| Net Profit | 14 | 12 | 14 | 17 | 23 | 21 | 23 | 21 | 30 | 23 | 30 | 31 | 31 | |
| EPS in Rs | 1.01 | 0.85 | 1.02 | 1.24 | 1.64 | 1.51 | 1.69 | 1.54 | 2.16 | 1.42 | 1.87 | 1.96 | 1.96 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202658.39%Promoter
Promoters58.39%
FIIs12.45%0.17
DIIs1.91%0.49
Public21.07%0.31
Government6.16%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,448.00 | 57.74 | 1,21,469 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹669.15 | 99.41 | 88,018 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹860.00 | 58.93 | 83,705 | 0.23% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Aster DM Quality | ₹681.15 | 164.50 | 59,374 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹768.15 | 54.36 | 57,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,720.20 | 38.85 | 35,154 | 0.26% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| Global Health | ₹1,270.30 | 59.66 | 34,156 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Artemis Medicare | ₹293.20 | 39.88 | 4,642 | 0.15% | 31 | +3.30% | 306 | +13.32% | 14.53% |
| Median: 31 Co. | ₹509.20 | 44.38 | 6,363 | 0.00% | 30 | +17.80% | 403 | +22.28% | 14.62% |
Filings
Annual reports7
Concall transcripts24
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Monitoring Agency Report 30 Oct - CARE issued Q2FY27 monitoring report for ₹330 crore preferential issue; no deviation reported, ₹10.36 crore utilized.Announcement under Regulation 30 (LODR)-Investor Presentation 30 Oct - Earnings Presentation - Q2 and H1 FY27Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Oct - Artemis reported Q2 FY27 revenue of Rs 31,104 lakhs; PAT up 3.7%, Raipur hospital launched July 2026.Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter/ Half Year Ended September 30, 2026 30 Oct - Board approved Q2 FY26 results; Raipur 300-bed hospital soft-launched in July 2026.Board Meeting Outcome for Board Meeting Held On October 30, 2026 30 Oct - Q2 FY27 results approved; 300-bed Raipur hospital soft-launched in July 2026.